AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Morgan Stanley Downgrades Lam Research from Equal-Weight to Underweight with Lowered Price Target of $92.00
ByAinvest
Tuesday, Sep 2, 2025 5:32 pm ET1min read
Morgan Stanley has downgraded Lam Research (LRCX) from "Equal-Weight" to "Underweight," lowering the price target from $94.00 to $92.00. This cautious outlook contrasts with positive sentiment from other firms. Analysts predict an average target price of $109.64, implying a 9.47% upside from the current price. The average brokerage recommendation is 2.0, indicating "Outperform" status.
Morgan Stanley has downgraded Lam Research (LRCX) from "Equal-Weight" to "Underweight," lowering its price target from $94.00 to $92.00 [1]. This move by the investment bank reflects concerns over a future slowdown in growth, particularly in Lam Research's key markets in China and the NAND memory sector. The firm expects system shipment growth to decelerate dramatically from an estimated 82% in 2025 to just 3% in 2026 [2].The downgrade comes amid broader negativity across the semiconductor sector, which experienced a wider selloff. Lam Research's stock has been quite volatile, with 19 moves greater than 5% over the last year. Despite the recent drop, the stock has surged 32.7% since the beginning of the year, trading at $96.10 per share [1].
Other analysts, however, maintain a positive outlook. They predict an average target price of $109.64, implying a 9.47% upside from the current price. The average brokerage recommendation is 2.0, indicating an "Outperform" status [2]. This positive sentiment is reflected in recent quarterly results, which exceeded expectations and led several firms to raise their price targets for Lam Research [3].
Investors should consider the potential impact of the downgrade and the broader market sentiment. While the stock's volatility presents opportunities, the slowdown in growth drivers could weigh on performance in the coming year. It's essential to monitor the company's financial health and market conditions to make informed investment decisions.
References:
[1] https://finance.yahoo.com/news/why-lam-research-lrcx-stock-162620001.html
[2] https://www.investing.com/news/analyst-ratings/morgan-stanley-downgrades-lam-research-stock-on-slowing-growth-outlook-93CH-4217821
[3] https://www.cnbc.com/2025/09/02/morgan-stanley-downgrades-lam-research-sees-a-challenging-setup-in-2026.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet